Physician profile
Thomas D Stuckey
NPI 1376593731
$36,488.67
in general payments reported to CMS, 2019-2025
18 companies · $1,975 in 2025
The $1,975 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $13K · 2021: $4,416 · 2022: $1,673 · 2023: $832 · 2024: $77.70 · 2025: $1,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Travel and Lodging: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.53 |
| Travel and Lodging | $1,271.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $30,281.22 | 2019-2021 | |
| Medtronic, INC. | $1,850.31 | 2023-2025 | Reveal Linq, Onyx Frontier |
| Actelion Pharmaceuticals, Ltd | $1,021.63 | 2022 | |
| Abiomed | $880.40 | 2019 | |
| Cvrx, INC. | $785.80 | 2019-2025 | Barostim Neo System |
| Abbott Laboratories | $551.02 | 2019-2025 | Dragonfly Opstar, Optis |
| Amgen INC. | $250.58 | 2022-2024 | Repatha |
| Boston Scientific Corporation | $171.42 | 2022 | |
| Heartflow, INC. | $124.54 | 2019-2023 | Ffrct |
| Teleflex LLC | $123.88 | 2019 | |
| Impulse Dynamics (USA) INC. | $114.63 | 2023 | Optimizer |
| Livanova USA, INC. | $111.63 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $96.60 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.64 | 2023 | Lifevest |
| Edwards Lifesciences Corporation | $29.37 | 2023 | Pascal |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Stuckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.